Literature DB >> 2331566

The combined electrophysiological effects of lignocaine and sotalol in canine isolated cardiac Purkinje fibres are rate-dependent.

D A Lathrop1, A Varró.   

Abstract

1. The frequency-dependent electrophysiological effects of lignocaine, sotalol, and their combination were studied in dog isolated cardiac Purkinje fibres, both at various constant rates of stimulation and following abrupt changes in pacing cycle length. 2. The combined effect of 18 microM lignocaine and 30 microM sotalol selectively lengthened duration of premature action potentials evoked at a diastolic interval of 40 ms (from 172.2 +/- 5.4 to 201.7 +/- 4.9 ms, n = 6, P less than 0.01) without significantly changing the durations of action potentials evoked at the basic cycle length of 500 ms (259.1 +/- 7.7 vs 251.9 +/- 3.9 ms, n = 11). 3. The combination of lignocaine with sotalol, like lignocaine alone, displayed a use-dependent depression of Vmax and revealed a slow component for a recovery of Vmax (tau = 173.5 +/- 16.0 ms, n = 5). 4. The kinetics for restitution of action potential duration were also slowed by the combination of the two dwo drugs (tau f = 173.6 +/- 16.7, before, vs 268.5 +/- 8.5 ms, after; n = 5, P less than 0.01), while the maximum action potential duration attained in this relation was not increased as it was by sotalol alone. 5. Lignocaine, therefore, appeared to inhibit the sotalol-induced lengthening of action potential duration at slow pacing rates and at long diastolic intervals. The combination of lignocaine with sotalol also completely abolished the occurrence of sotalol-induced early after depolarizations. 6. Finally, sotalol alone moderately increased the range of premature action potential durations, while the combination of the two drugs significantly decreased this parameter. 7. These findings indicate that the combination of lignocaine with sotalol may provide important, and unique, beneficial electrophysiological alterations that might be expected to provide enhanced antiarrhythmic efficacy in patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331566      PMCID: PMC1917517          DOI: 10.1111/j.1476-5381.1990.tb14665.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Effect of antiarrhythmic drugs on the cycle length-dependent action potential duration in dog Purkinje and ventricular muscle fibers.

Authors:  A Varro; Y Nakaya; V Elharrar; B Surawicz
Journal:  J Cardiovasc Pharmacol       Date:  1986 Jan-Feb       Impact factor: 3.105

Review 2.  Rationale of combination antiarrhythmic drug therapy.

Authors:  J L Anderson
Journal:  Cardiovasc Clin       Date:  1985

Review 3.  Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.

Authors:  L M Hondeghem; B G Katzung
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

4.  Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers.

Authors:  A Varro; V Elharrar; B Surawicz
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

5.  Dispersion of monophasic action potential durations and activation times during atrial pacing, ventricular pacing, and ventricular premature stimulation in canine ventricles.

Authors:  C S Kuo; J P Amlie; K Munakata; C P Reddy; B Surawicz
Journal:  Cardiovasc Res       Date:  1983-03       Impact factor: 10.787

6.  Cycle length effect on restitution of action potential duration in dog cardiac fibers.

Authors:  V Elharrar; B Surawicz
Journal:  Am J Physiol       Date:  1983-06

7.  The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.

Authors:  A A Kinnaird; R Y Man
Journal:  Eur J Pharmacol       Date:  1984-03-16       Impact factor: 4.432

8.  Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.

Authors:  E Carmeliet
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

9.  Electromechanical characterization of the effects of racemic sotalol and its optical isomers on isolated canine ventricular trabecular muscles and Purkinje strands.

Authors:  D A Lathrop
Journal:  Can J Physiol Pharmacol       Date:  1985-12       Impact factor: 2.273

10.  Sotalol-induced torsade de pointes.

Authors:  P Rakovec; B Cercek; P Rode; A Brucan; M Horvat
Journal:  Cathet Cardiovasc Diagn       Date:  1984
View more
  1 in total

Review 1.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.